Evidence map›Paper›PMID 26492461›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2016

Reduced Baseline Sensitivity to Maraviroc Inhibition Among R5 HIV-1 Isolates From Individuals With Severe Immunodeficiency.

Ulf Karlsson, Johanna Repits, Liselotte Antonsson, Erik Cederfjäll, Bengt Ljungberg, Martin Ålenius, Alan Sabirsh, Magnus Gisslen, Joakim Esbjörnsson, Marianne Jansson

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ulf KarlssonDepartments of *Clinical Sciences †Laboratory Medicine ‡Experimental Medical Science, Lund University, Lund, Sweden §Department of Neuroscience, CNS and Pain, AstraZeneca R&D, Södertälje, Sweden ‖Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden ¶Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom **Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Johanna Repits
Liselotte Antonsson
Erik Cederfjäll
Bengt Ljungberg
Martin Ålenius
Alan Sabirsh
Magnus Gisslen
Joakim Esbjörnsson
Marianne Jansson

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, ViralAcquired Immunodeficiency SyndromeCCR5 Receptor AntagonistsCyclohexanesenv Gene Products, Human Immunodeficiency VirusHIV-1HumansMaravirocMutationTriazolesCCR5 Receptor AntagonistsCyclohexanesenv Gene Products, Human Immunodeficiency VirusMaravirocTriazoles

Identifiers

PMID26492461
PMCPMC4770368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.